The effects of Valette® on skin and hair:: A post-marketing surveillance study

被引:0
|
作者
Zimmermann, T [1 ]
Wisser, KH [1 ]
Dietrich, H [1 ]
机构
[1] Jenapharm GMBh & CO KG, Dept Med Affairs, D-07745 Jena, Germany
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The effects of Valette(R) - an oral contraceptive containing ethinyloestradiol 0.03 mg and the antiandrogenic progestogen dienogest 2.0 mg - on the skin and hair were surveyed over 63,474 cycles in 10,718 women in routine gynaecological practice. Improvements were greatest in women with severe or moderate androgen-related symptoms. After six cycles, <1% of women had severely greasy hair and 6% had moderate greasiness, compared with 11% and 27% at baseline; fewer hair washes were needed per week. The incidence of severe and moderately greasy skin disorders fell from 16% to <1%, and from 39% to 7.5%, respectively. Self-assessments indicated less greasy hair and improved greasy skin disorders in 70% and 81% of women, respectively. The overall effect of Valette on the skin and hair was rated very good or good by 87.5% of women. These results confirm previous observations of a beneficial effect of Valette on androgen-related skin and hair conditions.
引用
收藏
页码:85 / +
页数:5
相关论文
共 50 条
  • [31] The need for a post-marketing surveillance program in Israel
    Shemer, J
    [J]. ISRAEL MEDICAL ASSOCIATION JOURNAL, 1999, 1 (02): : 98 - 99
  • [32] Post-marketing surveillance of the safety of levofloxacin in Japan
    Yamaguchi, Hiroki
    Kawai, Hitomi
    Matsumoto, Takuyuki
    Yokoyama, Hiroo
    Nakayasu, Toshio
    Komiya, Masahiro
    Shimada, Jingoro
    [J]. CHEMOTHERAPY, 2007, 53 (02): : 85 - 103
  • [33] POST-MARKETING SURVEILLANCE - HOW MANY PATIENTS
    LEWIS, JA
    [J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 1981, 2 (04) : 93 - 94
  • [34] POST-MARKETING SURVEILLANCE OF ADVERSE DRUG EXPERIENCES
    CAPPUCCI, DR
    TURNER, NJ
    KLINCK, PC
    BEAULIEU, AJ
    GRAVES, WL
    [J]. JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION, 1981, 179 (03) : 264 - 264
  • [35] Post-marketing surveillance: a UK/European perspective
    Gough, S
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2005, 21 (04) : 565 - 570
  • [36] RESULTS OF POST-MARKETING SURVEILLANCE PROGRAM ON STREPTOKINASE
    THAYER, CF
    [J]. CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1981, 30 (01): : 129 - 140
  • [37] Post-marketing surveillance and adverse drug reactions
    Shani, S
    [J]. ISRAEL MEDICAL ASSOCIATION JOURNAL, 1999, 1 (02): : 117 - 119
  • [38] Post-marketing surveillance of modafinil abuse and misuse
    Smith, DE
    Calhoun, SR
    Galloway, GP
    Romanoff, SJ
    Wolfe, NE
    [J]. SLEEP, 2004, 27 : 57 - 57
  • [40] Effectiveness and tolerability of parenteral testosterone undecanoate: a post-marketing surveillance study
    Wolf, Jan
    Keipert, Dieter
    Motazedi, Heiko
    Ernst, Michael
    Nettleship, Joanne
    Gooren, Louis
    [J]. AGING MALE, 2017, 20 (04): : 225 - 234